Negative Pressure Wound Therapy (NPWT) Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,350	185 Pages	DataM Intelligence 4Market Research LLP	March, 2024	DTAM18600011

Best Price Guarantee
Price	from $4,350
Length	185 Pages
Publisher	DataM Intelligence 4Market Research LLP
Published Date	March, 2024
SKU	DTAM18600011

Negative Pressure Wound Therapy (NPWT) Market

Global Negative Pressure Wound Therapy (NPWT) Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2031 growing at a CAGR of YY% during the forecast period 2024-2031.

Negative Pressure Wound Therapy (NPWT) is a therapeutic method for healing second and third-degree burns, and chronic or acute wounds that use a suction pump, tubing, and dressing to remove excess exudate.

Negative Pressure Wound Therapy (NPWT) promotes angiogenesis by increasing blood flow to the wound site. Enhanced perfusion delivers oxygen and nutrients to the wound bed, supporting cellular proliferation, tissue regeneration, and collagen synthesis, which are essential for wound healing.

Market Dynamics

Growing prevalence of chronic wounds

The increasing prevalence of chronic wounds acts as a significant driver for market growth. Chronic wounds include various types, such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and non-healing surgical wounds.

For instance, the annual incidence of diabetic foot ulcers worldwide is between 9.1 to 26.1 million. Around 15 to 25% of patients with diabetes mellitus develop a diabetic foot ulcer during their lifetime. Also, the number of adult diabetic patients in China is a total of 116.4 million among which the incidence of diabetic foot (DF) is as high as 30%.

Additionally, according to the Canadian Maple report, there are between 77,600 and 116,400 diabetic foot ulcers in Canada and up to 25% of the nearly 4 million Canadians living with diabetes will develop a diabetic foot ulcer (DFU) in their lifetime, with a 20% associated risk of limb loss.

Furthermore, significant growth drivers such as the rising technological advancements for NPWT devices, and the rising traumatic accidents are expected to drive the market in the forecast period.

Risk of complications

Negative Pressure Wound Therapy (NPWT) can help reduce the risk of infection by removing exudate and promoting wound healing. However, improper application or maintenance of NPWT can lead to wound contamination or infection. Also, prolonged negative pressure applied to the wound bed can cause skin irritation, blistering, or trauma around the wound site.

Segment Analysis

The global negative pressure wound therapy (NPWT) market is segmented based on device type, dressings, wound type, end users and region.

The polysaccharides segment accounted for approximately 56.4% of the market share

The polysaccharides segment is expected to hold the largest market share over the period forecast. Polysaccharide dressings are made from natural or synthetic materials derived from sugars. They are designed to provide a moist wound healing environment, facilitate autolytic debridement, and promote tissue regeneration

Some polysaccharide dressings also possess antimicrobial properties which helps to reduce the risk of wound infection and support the healing process. It can also conform to the wound contours, providing comfort to the patient and minimizing trauma during dressing changes.

For instance, in August 2023, Medela expanded its negative pressure wound therapy (NPWT) portfolio by introducing the new Invia Integrated Dressing indicated for all types of wounds. It has a three-layer fluid handling pad that has a skin-friendly silicone adhesive border.

Geographical Analysis

North America is expected to hold a significant position in the global portable medical devices market share

The global negative pressure wound therapy (NPWT) market is segmented into North America, Europe, Asia Pacific, South America, Middle East and Africa.

North America has maintained a significant market proportion due to factors such as the increasing prevalence of diabetes, technological advancements, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.

For instance, in April 2023, 3M Veraflo Therapy dressings received the FDA clearance for hydromechanical removal of non-viable tissue. It is the only negative pressure wound therapy (NPWT) dressing that hydromechanically removes non-viable tissue.

Additionally, according to the Centers for Disease Control and Prevention report 2021, diabetes prevalence significantly increased among US adults 18 or older. Around,38.4 million people have diabetes which is 11.6% of the US population. Hence, the rising prevalence of diabetes can lead to diabetic foot ulcers.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global negative pressure wound therapy (NPWT) market. The market faced challenges related to supply chain disruptions, manufacturing delays, and shortages of raw materials and components due to lockdowns, travel restrictions, and disruptions in global trade. However, the patients with COVID-19-related complications, prolonged hospitalizations, and limited mobility were at higher risk of developing wounds, which led to the use of NPWT and other advanced wound therapies. Therefore, owing to the above factors, the negative pressure wound therapy (NPWT) market was moderately affected over the forecast period.

Market Segmentation

By Device Type
• Conventional NPWT Systems
• Single-use NPWT Devices

By Dressings
• Polysaccharides
Silicone Dressings
Non-Silicone Dressings
• Hydrocolloids Dressings
• Gauze Dressings
• Drapes
• Others

By Wound Type
• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Burns
• Surgical & Traumatic Wounds
• Others

By End User
• Hospital & Clinics
• Homecare
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include 3M Company, Advin Health Care, Medela AG, Gilero, Smith & Nephew Plc, Cardinal Health Inc., Convatec Inc., Talley Group Ltd, Mölnlycke Health Care AB, and DeRoyal among others.

Key Developments
• In May 2023, Smith+Nephew received an Innovative Technology contract from Vizient, Inc. for its PICO Single Use Negative Pressure Wound Therapy Systems. The PICO sNPWT System provides a portable, easy to use, canister-free design and is equipped with the comfort and mobility of Smith+Nephew soft port technology.

Why Purchase the Report?
• To visualize the global negative pressure wound therapy (NPWT) market segmentation based on device type, dressings, wound type and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global negative pressure wound therapy (NPWT) market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global negative pressure wound therapy (NPWT) market report would provide approximately 61 tables, 58 figures, and 185 Pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

1. Methodology and Scope: 1.1. Research Methodology; 1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary: 3.1. Snippet by Device Type; 3.2. Snippet by Dressings; 3.3. Snippet by Wound Type; 3.4. Snippet by End Users; 3.5. Snippet by Region
4. Market Dynamics: 4.1. Impacting Factors; 4.1.1. Drivers; 4.1.1.1. Growing prevalence of chronic wounds; 4.1.1.2. YY; 4.1.2. Restraints; 4.1.2.1. Risk of complications; 4.1.2.2. YY; 4.1.3. Opportunity; 4.1.4. Impact Analysis
5. Industry Analysis: 5.1. Porter's Five Force Analysis; 5.2. Supply Chain Analysis; 5.3. Pricing Analysis; 5.4. Regulatory Analysis; 5.5. DMI Opinion
6. COVID-19 Analysis: 6.1. Analysis of COVID-19; 6.1.1. Scenario Before COVID; 6.1.2. Scenario During COVID; 6.1.3. Scenario Post COVID; 6.2. Pricing Dynamics Amid COVID-19; 6.3. Demand-Supply Spectrum; 6.4. Government Initiatives Related to the Market During Pandemic; 6.5. Manufacturers Strategic Initiatives; 6.6. Conclusion
7. By Device Type: 7.1. Introduction; 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type; 7.1.2. Market Attractiveness Index, By Device Type; 7.2. Conventional NPWT Systems*; 7.2.1. Introduction; 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 7.3. Single-use NPWT Devices
8. By Dressings: 8.1. Introduction; 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dressings; 8.1.2. Market Attractiveness Index, By Dressings; 8.2. Polysaccharides*; 8.2.1. Introduction; 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 8.2.3. Silicone Dressings; 8.2.4. Non-Silicone Dressings; 8.3. Hydrocolloids Dressings; 8.4. Gauze Dressings; 8.5. Drapes; 8.6. Others
9. By Wound Type: 9.1. Introduction; 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type; 9.1.2. Market Attractiveness Index, By Wound Type; 9.2. Diabetic Foot Ulcers*; 9.2.1. Introduction; 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 9.3. Pressure Ulcers; 9.4. Venous Leg Ulcers; 9.5. Burns; 9.6. Surgical & Traumatic Wounds; 9.7. Others
10. By End User: 10.1. Introduction; 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 10.1.2. Market Attractiveness Index, By End User; 10.2. Hospital & Clinics*; 10.2.1. Introduction; 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 10.3. Homecare; 10.4. Others
11. By Region: 11.1. Introduction; 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region; 11.1.2. Market Attractiveness Index, By Region; 11.2. North America; 11.2.1. Introduction; 11.2.2. Key Region-Specific Dynamics; 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type; 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dressings; 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type; 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 11.2.7.1. U.S.; 11.2.7.2. Canada; 11.2.7.3. Mexico; 11.3. Europe; 11.3.1. Introduction; 11.3.2. Key Region-Specific Dynamics; 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type; 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dressings; 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type; 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 11.3.7.1. Germany; 11.3.7.2. UK; 11.3.7.3. France; 11.3.7.4. Italy; 11.3.7.5. Spain; 11.3.7.6. Rest of Europe; 11.4. South America; 11.4.1. Introduction; 11.4.2. Key Region-Specific Dynamics; 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type; 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dressings; 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type; 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 11.4.7.1. Brazil; 11.4.7.2. Argentina; 11.4.7.3. Rest of South America; 11.5. Asia-Pacific; 11.5.1. Introduction; 11.5.2. Key Region-Specific Dynamics; 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type; 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application; 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 11.5.6.1. China; 11.5.6.2. India; 11.5.6.3. Japan; 11.5.6.4. Australia; 11.5.6.5. Rest of Asia-Pacific; 11.6. Middle East and Africa; 11.6.1. Introduction; 11.6.2. Key Region-Specific Dynamics; 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type; 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dressings; 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type; 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape: 12.1. Competitive Scenario; 12.2. Market Positioning/Share Analysis; 12.3. Mergers and Acquisitions Analysis
13. Company Profiles: 13.1. 3M Company; 13.1.1. Company Overview; 13.1.2. Product Portfolio and Description; 13.1.3. Financial Overview; 13.1.4. Key Developments; 13.2. Advin Health Care; 13.3. Medela AG; 13.4. Gilero; 13.5. Smith & Nephew Plc; 13.6. Cardinal Health Inc.; 13.7. Convatec Inc.; 13.8. Talley Group Ltd; 13.9. Mölnlycke Health Care AB; 13.10. DeRoyal; LIST NOT EXHAUSTIVE
14. Appendix: 14.1. About Us and Services; 14.2. Contact Us